Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-27
2006-06-27
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S422000, C548S524000, C548S953000
Reexamination Certificate
active
07067509
ABSTRACT:
Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure:including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, R1, R2, R3, R4, R5, and R6are as defined herein. Pharmaceutical compositions containing a compound of this invention, as well as methods relating to the use thereof, are also disclosed.
REFERENCES:
patent: 4576749 (1986-03-01), Zahler et al.
patent: 5652249 (1997-07-01), Kimura et al.
patent: 6734176 (2004-05-01), Achard et al.
patent: 2002/0052383 (2002-05-01), Bakthavatchalam et al.
patent: 2003/0216380 (2003-11-01), Josien et al.
patent: 2001272751 (2001-10-01), None
patent: WO 01/21169 (2001-03-01), None
patent: WO 01/21577 (2001-03-01), None
patent: WO 01/82925 (2001-11-01), None
patent: WO 01/87834 (2001-11-01), None
patent: WO 01/94368 (2001-12-01), None
patent: WO 02/04433 (2002-01-01), None
patent: WO 02/06245 (2002-01-01), None
patent: WO 02/057233 (2002-07-01), None
patent: WO 02/076929 (2002-10-01), None
patent: WO 2003013527 (2003-02-01), None
Whooley, M., and Simon, G., “Managing Depression in Medical Outpatients,” New Engl. J. Med., vol. 343(26), pp. 1942-1950 (Dec. 2000), at p. 1946, line 4 (Table 4).
Nakamura, K., and Tanaka, Y., “Antidepressant-like effects of aniracetam in aged rats and its mode of action,” Psychopharmacology, vol. 158(2), pp. 205-212 (Nov. 2001), at Abstract; p. 210, col. 2, lines 58-59 and p. 211, lines 1-2.
Derwent World Patents Index, English Abstract of JP 2001-226269, Aug. 21, 2001.
Bednarek, M., et al., “Synthesis and Biological Evaluation in Vitro of a Selective, High Potency Peptide Agonist of Human Melanin-concentrating Hormone Action at Human Melanin-Concentrating Hormone Receptor 1,”J. Biol. Chem. 277(16):13821-6, Apr. 19, 2002.
Takekawa, S., et al., “T-226296: A Novel, Orally Active and Selective Melanin-concentrating Hormone Receptor Antagonist,”Eur. J. Pharmacol. 438(3):129-35, Mar. 8, 2002.
Clough Sarah
Dyck Brian P
Goodfellow Val
Grey Jonathan
Kiankarimi Mehrak
Neurocrine Biosciences Inc.
Paviglianiti Anthony J.
Solola Taofiq
LandOfFree
Melanin-concentrating hormone receptor antagonists and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanin-concentrating hormone receptor antagonists and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanin-concentrating hormone receptor antagonists and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3654288